Stay updated with breaking news from Boris Peaker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lilly set Dec. 15 as the deadline in a third extension. The Indianapolis-based drugmaker maintained its offer price at $12.50 per share, which is over 10% lower than Point Biopharma's last closing price of $13.80. Lilly had struck a $1.4 billion deal to buy Point Biopharma in October.
(Reuters) - Eli Lilly on Monday again extended its deadline for Point Biopharma Global shareholders to sell their shares to the drugmaker, following ...
Operator: Greetings, and welcome to the Celcuity Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Operator: Good day, and thank you for standing by. Welcome to the Aadi Bioscience Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Operator: Good morning, and thank you for joining the GlycoMimetics Q3 2023 Earnings Call. At this time, all participants are in a listen-only mode.